| Host: |
HEK293 cells |
| Reactivity: |
SARS-CoV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-CoV-2 Spike RBD (B.1.640.2/IHU)-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: |
Immobilized SARS-Cov-2 Spike RBD (B.1.640.2/IHU) , His Tag at 0.5 Mu g/mL (100 Mu L/well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 41.3 ng/mL determined by ELISA. |
| Immunogen Region: |
Arg319-Phe541 |
| Immunogen: |
Recombinant SARS-CoV-2 (2019-nCoV) Spike RBD (B.1.640.2/IHU)-His Protein is produced by Expi293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541 (R346S, N394S, Y449N, E484K, F490S, N501Y) ) of SARS-COV-2 (2019-nCo |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
